Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland.
Nat Immunol. 2013 Oct;14(10):1045-53. doi: 10.1038/ni.2704. Epub 2013 Sep 1.
Chronic inflammation is a fundamental aspect of metabolic disorders such as obesity, diabetes and cardiovascular disease. Cholesterol crystals are metabolic signals that trigger sterile inflammation in atherosclerosis, presumably by activating inflammasomes for IL-1β production. We found here that atherogenesis was mediated by IL-1α and we identified fatty acids as potent inducers of IL-1α-driven vascular inflammation. Fatty acids selectively stimulated the release of IL-1α but not of IL-1β by uncoupling mitochondrial respiration. Fatty acid-induced mitochondrial uncoupling abrogated IL-1β secretion, which deviated the cholesterol crystal-elicited response toward selective production of IL-1α. Our findings delineate a previously unknown pathway for vascular immunopathology that links the cellular response to metabolic stress with innate inflammation, and suggest that IL-1α, not IL-1β, should be targeted in patients with cardiovascular disease.
慢性炎症是肥胖、糖尿病和心血管疾病等代谢紊乱的一个基本方面。胆固醇晶体是代谢信号,可在动脉粥样硬化中引发无菌性炎症,推测是通过激活炎性小体来产生 IL-1β。我们在这里发现,动脉粥样硬化是由 IL-1α介导的,并且我们确定脂肪酸是强有力的 IL-1α 驱动的血管炎症诱导剂。脂肪酸通过解偶联线粒体呼吸选择性刺激 IL-1α 的释放,但不刺激 IL-1β 的释放。脂肪酸诱导的线粒体解偶联阻断了 IL-1β 的分泌,这使胆固醇晶体引发的反应偏向于选择性产生 IL-1α。我们的研究结果描绘了一条以前未知的血管免疫病理学途径,它将细胞对代谢应激的反应与先天炎症联系起来,并表明在心血管疾病患者中,应该针对 IL-1α 而不是 IL-1β。